September 22, 2016
The Ethics & Morality of Robotic Warfare: Assessing the Debate over Autonomous Weapons
There is growing concern in some quarters that the drones used by the United States and others represent precursors to the further automation of military force through the use of lethal autonomous weapon systems (LAWS). These weapons, though they do not generally exist today, have already been the subject of multiple discussions at the United Nations. Do autonomous weapons raise unique ethical questions for warfare, with implications for just war theory? This essay describes and assesses the ongoing debate, focusing on the ethical implications of whether autonomous weapons can operate effectively, whether human accountability and responsibility for autonomous weapon systems are possible, and whether delegating life and death decisions to machines inherently undermines human dignity. The concept of LAWS is extremely broad and this essay considers LAWS in three categories: munition, platforms, and operational systems.
Read the full report here.
More from CNAS
-
Biotech Matters: Public-Private Coordination of Biotechnology
An appreciation of biotechnology’s great opportunities is, for many commentators, intimately joined with regret about a disconnect between the U.S. government and the private ...
By Richard Danzig
-
$6.6 billion TSMC deal in Arizona the latest in the CHIPS Act’s rollout
“President Biden signed the CHIPS and Science Act just about 20 months ago, which in government time is yesterday. And they’ve hired 200 people,” said Vivek Chilukuri, a senio...
By Vivek Chilukuri
-
Response to NTIA Request for Comment: “Dual Use Foundation Artificial Intelligence Models with Widely Available Model Weights”
In February 2024, the Department of Commerce’s National Telecommunications and Information Administration (NTIA) issued a Request for Comment (RFC) on the implications of “ope...
By Caleb Withers
-
Biotech Matters: Great Data Competition and Interoperability with Allies and Partners
Understanding and strengthening America’s biotechnology leadership requires exploring the limits of existing data relevant to the U.S. bioeconomy so that policymakers and the ...
By Michelle Holko